Triple-negative breast cancer (TNBC) that does not express estrogen receptor (ER), progesterone receptor (PR), and HER-2/neu is the most aggressive sub-type of breast cancer. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.